Clinical trial
Multiomics Targeting Microbiome Associated Changes in Stroke Patients (StrokeMicroBiomics)
NCT04315922 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multiomics Targeting Microbiome Associated Changes in Stroke Patients (StrokeMicroBiomics)
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 16, 2019
- Completion date
- June 1, 2023
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, transient ischemic attack